Comparative Analysis of Healthcare Fraud Laws in the United States and India: Enforcement, Gaps, and Reforms
Tanmoy Bhattacharyya (Advocate)
February 13, 2026
Healthcare fraud functions as a corrosive force that steadily siphons vitality from modern health systems, depleting funds intended for essential care and undermining public faith in medical institutions. As global healthcare coverage expands and digital claim infrastructures evolve, deceptive practices—highlight: inflated invoicing, artfully contrived procedures, fictitious patient files—intensify inequities and impose immense financial strain. This recrafted analysis explores the legal and enforcement architectures confronting healthcare fraud in United States and India, two nations positioned in starkly different economic and regulatory universes. Grounded in a normative–comparative legal method, the study interprets statutory language, institutional configurations, and judicial tendencies to expose disparities in conceptual precision, bureaucratic cohesion, and enforcement vigor.
Drawing from legislative materials, enforcement archives, case narratives, and scholarly evaluations, the inquiry illuminates dissonances between the American model—an intricately layered enforcement ecosystem—and India’s more diffuse, generalist legal pathway. In the U.S., a carefully interlinked suite of civil, criminal, and administrative instruments, supported by specialized agencies such as U.S. Department of Justice, Federal Bureau of Investigation, and Health and Human Services Office of Inspector General, enables targeted, high-tempo responses to fraudulent conduct. Conversely, India leans on broad-spectrum provisions in its new criminal code, anti-corruption statutes, and digital-fraud laws, supplemented by regulatory advisories from bodies like the Insurance Regulatory and Development Authority of India and National Health Authority, but without a sector-specific anti-fraud statute. The result is a more fragmented infrastructure with diffuse accountability.
Normative analysis here assesses whether legal principles sufficiently honor ethical imperatives such as patient protection and fiscal stewardship, while comparative analysis juxtaposes institutions across federal systems influenced by divergent political economies. Primary American sources include established fraud-control statutes, whistleblower frameworks, and oversight mechanisms, accompanied by data from agencies such as Centers for Medicare & Medicaid Services. Indian primary sources encompass the Bharatiya Nyaya Sanhita 2023, the Prevention of Corruption Act, Information Technology Act provisions, and regulatory circulars. Secondary references extend to oversight reports from agencies like the World Bank, academic assessments, and adjudicatory precedents.
U.S. law articulates healthcare fraud with striking specificity, addressing diverse manifestations ranging from false reimbursement claims to covert kickback arrangements. One of its most potent instruments, the False Claims Act, attaches substantial civil liability—including treble damages—and incorporates a highlight: qui tam whistleblower pathway that has produced multibillion-dollar recoveries, including $5.3 billion in FY2025. The Anti-Kickback Statute criminalizes remuneration-for-referral schemes tied to federal programs, while the Stark Law imposes strict civil liability for physician self-referrals. The Health Care Fraud Statute further criminalizes deceptive schemes targeting health benefit programs, with penalties escalating dramatically when harm or death ensues. These provisions operate within an enforcement superstructure shaped by HIPAA’s Health Care Fraud and Abuse Control Program, which coordinates investigative and prosecutorial activities.
American enforcement displays high specialization and strategic sophistication. The DOJ’s Health Care Fraud Unit deploys more than seventy prosecutors and collaborates with geographically based Strike Forces that utilize algorithmic analyses to identify anomalous billing patterns. The highlight: Healthcare Fraud Prevention Partnership unites federal agencies and private insurers to illuminate systemic vulnerabilities. Annual enforcement drives, such as the National Health Care Fraud Takedowns, demonstrate the breadth of action: in 2025, 324 individuals were charged in schemes totaling $14.6 billion, including transnational operations fabricating durable medical equipment claims. Jurisprudence—including influential decisions refining materiality and intent—continues to sculpt enforcement boundaries. Meanwhile, systematic public reporting, including audits and payment-suspension notices, reinforces transparency. Sentencing data reflects genuine deterrence, with hundreds of convictions and average prison terms nearing thirty months.
In India, the legal environment is comparatively diffuse. The Bharatiya Nyaya Sanhita furnishes general fraud-related offenses—highlight: cheating, document fabrication, collusive conspiracies—that can be applied to healthcare contexts but do not define healthcare fraud as a distinct legal category. The Prevention of Corruption Act captures bribery and illicit inducements in referrals or scheme authorizations, while the Information Technology Act penalizes impersonation and digital-fraud scenarios. Regulatory guidance—such as IRDAI’s anti-fraud requirements—mandates internal controls but imposes no standalone civil liability regime. Large health-insurance programs like Ayushman Bharat Pradhan Mantri Jan Arogya Yojana rely on contractual remedies such as de-empanelment, paired with referrals to ordinary criminal procedure. Owing to the absence of a unified statutory definition, “fraud” spans overbilling, fabricated medical records, unnecessary procedures, and contrived claims—losses estimated at highlight: 6–12 percent of national health spending, reaching even higher figures in certain regions.
India’s enforcement institutions exhibit limited specialization and coordination. High-value investigations may reach the Central Bureau of Investigation, but routine matters are handled by state police or insurance investigators, many of whom lack healthcare expertise. The National Anti-Fraud Unit under ABPMJAY identifies a small fraction of suspicious cases, relying heavily on manual audits instead of predictive analytics. Studies funded by the World Bank have documented insufficient fraud-management frameworks in several states, where sanctions often stop at temporary blacklisting. Judicial decisions rarely differentiate healthcare fraud from other deceit offenses, resulting in case law that does not adapt to the complexities of medical documentation, clinical discretion, or insurance protocols. Transparency deficits—no centralized reporting mechanism, sporadic publication of fraud statistics, and inconsistent administrative follow-through—compound enforcement weaknesses. Large-scale manipulations, including falsified patient files and mass overcharging episodes, contribute to annual losses estimated at highlight: ₹10,000 crore.
The comparative portrait reveals pronounced divergences. The U.S. system benefits from sharply defined fraud categories, coordinated investigative bodies, data-centric detection models, strong whistleblower incentives, and well-developed judicial doctrine. These attributes strengthen deterrence and ensure systematic recoupment of improperly expended funds. India’s architecture, by contrast, resembles an unassembled mosaic: legal ambiguity, siloed institutions, generalist courts, resource shortages, and reactive policing dilute the efficacy of enforcement. While the United States incurs fraud costs estimated at 3–10 percent of healthcare expenditure, India’s proportionally higher losses underscore institutional vulnerabilities that directly aggravate already substantial out-of-pocket spending.
Reform pathways emerge clearly. India could design a dedicated Healthcare Fraud Act articulating precise offenses, delineating safe-harbor provisions, and embedding whistleblower incentives analogous to American qui tam actions. Civil monetary penalties could be authorized for regulators such as IRDAI and the NHA, paralleling U.S. administrative frameworks. A national Health Care Fraud Task Force—uniting the CBI, NHA, state authorities, and technical experts—could implement regionally deployed strike teams supported by AI-driven anomaly detection. Judicial specialization, through dedicated benches or expert panels, would enrich doctrinal clarity. Mandated fraud-reporting dashboards and public data releases could elevate transparency. Pilot initiatives launched in high-incidence states would allow systematic testing of these innovations.
This reinterpreted study fills a persistent void in Indian legal scholarship, where healthcare fraud is seldom examined independently of larger corruption discourse. By juxtaposing American institutional sophistication with Indian structural deficits, it advocates reforms that could safeguard the Ayushman Bharat program’s financial integrity—protecting its highlight: ₹5-lakh coverage for nearly half a billion beneficiaries—and tempering the sizeable losses that threaten its sustainability. India’s adoption of adaptable U.S.-inspired strategies, grounded in contextual realities, promises a sturdier, more ethically coherent health-governance framework capable of protecting vulnerable populations and restoring systemic trust.
Bibliography
1. Butterworth, James; Reynolds, Lydia. Health Care Fraud and Abuse: Enforcement and Compliance. Wolters Kluwer, 2022.
An authoritative treatise outlining U.S. healthcare-fraud statutes, compliance architecture, and federal enforcement.
Excerpt: “Contemporary fraud control depends not merely on legal prohibitions but on dynamic oversight ecosystems built around data analytics, inter-agency collaboration, and frontline compliance.”
2. Saha, Sanjay; Iyer, Shobitha. Regulating Health Insurance in India: Institutions, Markets, and Governance. Oxford University Press, 2021.
A comprehensive exploration of India’s health-insurance regulatory evolution, IRDAI rule-making, and fraud-control limitations.
Excerpt: “Despite impressive expansion of coverage, India’s regulatory posture remains fragmented, with anti-fraud responsibilities divided across agencies lacking coordinated mandates.”
3. U.S. Department of Justice. Annual Health Care Fraud and Abuse Control Program Report. Government Printing Office, 2025.
The DOJ’s flagship report documenting national healthcare-fraud enforcement, including prosecution numbers, financial recoveries, and strike-force activity.
Excerpt: “Civil and criminal resolutions recovered over five billion dollars this fiscal year, demonstrating the effectiveness of coordinated, data-driven enforcement.”
4. Health and Human Services Office of Inspector General. Semiannual Report to Congress. HHS-OIG Publications, 2024.
A transparent compilation of audits, investigative outcomes, exclusion statistics, and vulnerability analyses for U.S. federal health programs.
Excerpt: “Persistent hotspots—including durable medical equipment, telehealth billing, and opioid-related schemes—continue to challenge program integrity.”
5. Sharma, Neeraj; Thomas, Maya. Governance and Fraud Control in Indian Public Health Programs. Sage Publications, 2020.
A policy-focused volume examining fraud risks in Indian welfare schemes, with case studies from RSBY and state insurance programs.
Excerpt: “Fraud thrives where administrative capacities are thin, oversight tools outdated, and incentives misaligned with accountability.”
6. World Bank. Addressing Fraud and Corruption in India’s Health Insurance Schemes: A Diagnostic Study. World Bank Publications, 2023.
A major study diagnosing fraud typologies in Indian health-insurance systems, including ABPMJAY, with forensic statistical analysis.
Excerpt: “Across several states, detection rates remain below one percent, revealing systemic blind spots in claim-verification architecture.”
7. Brown, Timothy. False Claims Act Litigation and Compliance. American Bar Association Publishing, 2023.
A practitioner-oriented handbook tracing litigation trends, materiality doctrine, and whistleblower jurisprudence in the U.S.
Excerpt: “The post-Escobar landscape emphasizes fact-specific inquiries into whether misrepresentations could meaningfully influence payment decisions.”
8. Rao, Priyanka; Kulkarni, Aditya. Digital Fraud and the Information Technology Act in India. Eastern Book Company, 2022.
Explores digital-fraud typologies, cybersecurity vulnerabilities, and prosecutorial challenges under India’s IT Act.
Excerpt: “Health-sector digitization has expanded the attack surface, but enforcement still struggles with technical capacity gaps.”
9. Insurance Regulatory and Development Authority of India. Health Insurance Regulations and Anti-Fraud Framework. IRDAI Official Publication, 2016.
Regulatory guidelines prescribing anti-fraud policies, insurer obligations, and internal-control expectations in India’s private and public insurance markets.
Excerpt: “Insurers shall establish dedicated fraud-monitoring units; however, enforcement remains reliant on general criminal law mechanisms.”
10. Gupta, Leena. Corruption and Accountability in Indian Healthcare. Routledge, 2019.
A socio-legal study of corruption and fraud in India’s mixed health economy, with ethnographic insights from hospitals and insurance TPAs.
Excerpt: “The opacity of medical decision-making makes fraud easier to conceal, necessitating specialized oversight bodies.”
11. Centers for Medicare & Medicaid Services. Medicare Program Integrity Manual. CMS Publications, 2024.
CMS’s operational guide outlining claims-review protocols, fraud-detection methodologies, and administrative remedies such as payment suspensions.
Excerpt: “Program integrity requires continuous recalibration as fraud schemes adapt to regulatory and technological shifts.”
12. Desai, Vikram; Bhattacharya, Rukmini. Universal Health Coverage in India: Legal and Institutional Pathways. Cambridge University Press, 2023.
Analyzes India’s health-system reforms, legal frameworks underpinning ABPMJAY, and institutional deficits affecting program integrity.
Excerpt: “Without a dedicated fraud-control statute, universal health coverage risks becoming fiscally untenable.”
Read More
What Happens to an Obese Man’s Body After 36 Hours Without Sugar?
